Financhill
Sell
40

SPAI Quote, Financials, Valuation and Earnings

Last price:
$4.13
Seasonality move :
--
Day range:
$3.79 - $4.69
52-week range:
$1.56 - $6.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
37.64x
P/B ratio:
14.83x
Volume:
562.2K
Avg. volume:
2M
1-year change:
--
Market cap:
$62.8M
Revenue:
$917.7K
EPS (TTM):
--
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- -- -- $1.2M $917.7K
Revenue Growth (YoY) -- -- -- -- -20.24%
 
Cost of Revenues -- -- -- $632.1K $606.6K
Gross Profit -- -- -- $518.5K $311.1K
Gross Profit Margin -- -- -- 45.07% 33.9%
 
R&D Expenses -- -- -- -- $373.7K
Selling, General & Admin -- -- -- $945.5K $6.1M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- $1M $6.6M
Operating Income -- -- -- -$502.8K -$6.3M
 
Net Interest Expenses -- -- -- $4.8K $7.7K
EBT. Incl. Unusual Items -- -- -- -$507.6K -$6.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$507.6K -$6.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$507.6K -$6.3M
 
Basic EPS (Cont. Ops) -- -- -- -$0.04 -$0.46
Diluted EPS (Cont. Ops) -- -- -- -$0.04 -$0.46
Weighted Average Basic Share -- -- -- $13.7M $13.7M
Weighted Average Diluted Share -- -- -- $13.7M $13.7M
 
EBITDA -- -- -- -$397.4K -$6.1M
EBIT -- -- -- -$502.8K -$6.3M
 
Revenue (Reported) -- -- -- $1.2M $917.7K
Operating Income (Reported) -- -- -- -$502.8K -$6.3M
Operating Income (Adjusted) -- -- -- -$502.8K -$6.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $163.6K $330.8K
Revenue Growth (YoY) -- -- -- -- 102.24%
 
Cost of Revenues -- -- -- $101.1K $196.5K
Gross Profit -- -- -- $62.5K $134.2K
Gross Profit Margin -- -- -- 38.18% 40.58%
 
R&D Expenses -- -- -- $91.5K --
Selling, General & Admin -- -- -- $603.6K $3.6M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- $740.7K $3.7M
Operating Income -- -- -- -$678.2K -$3.5M
 
Net Interest Expenses -- -- -- $1.6K $143.4K
EBT. Incl. Unusual Items -- -- -- -$679.8K -$3.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$679.8K -$3.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$679.8K -$3.7M
 
Basic EPS (Cont. Ops) -- -- -- -$0.05 -$0.34
Diluted EPS (Cont. Ops) -- -- -- -$0.05 -$0.34
Weighted Average Basic Share -- -- -- $13.7M $10.8M
Weighted Average Diluted Share -- -- -- $13.7M $10.8M
 
EBITDA -- -- -- -$618.5K -$3.4M
EBIT -- -- -- -$678.2K -$3.5M
 
Revenue (Reported) -- -- -- $163.6K $330.8K
Operating Income (Reported) -- -- -- -$678.2K -$3.5M
Operating Income (Adjusted) -- -- -- -$678.2K -$3.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $1.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- $1M
Gross Profit -- -- -- -- $524K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- $215.5K
Selling, General & Admin -- -- -- -- $10.3M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- $10.7M
Operating Income -- -- -- -- -$10.2M
 
Net Interest Expenses -- -- -- $3.6K $298.6K
EBT. Incl. Unusual Items -- -- -- -- -$10.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- -$10.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- -$10.5M
 
Basic EPS (Cont. Ops) -- -- -- -- -$0.84
Diluted EPS (Cont. Ops) -- -- -- -- -$0.84
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -- -$9.9M
EBIT -- -- -- -- -$10.2M
 
Revenue (Reported) -- -- -- -- $1.6M
Operating Income (Reported) -- -- -- -- -$10.2M
Operating Income (Adjusted) -- -- -- -- -$10.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $640.1K $1.3M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $406.9K $835.3K
Gross Profit -- -- -- $233.2K $446.1K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $244K $85.8K
Selling, General & Admin -- -- -- $1.7M $5.9M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- $2.1M $6.2M
Operating Income -- -- -- -$1.9M -$5.7M
 
Net Interest Expenses -- -- -- $3.7K $294.5K
EBT. Incl. Unusual Items -- -- -- -$1.9M -$6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$1.9M -$6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$1.9M -$6M
 
Basic EPS (Cont. Ops) -- -- -- -$0.14 -$0.51
Diluted EPS (Cont. Ops) -- -- -- -$0.14 -$0.51
Weighted Average Basic Share -- -- -- $41M $38.1M
Weighted Average Diluted Share -- -- -- $41M $38.1M
 
EBITDA -- -- -- -$1.7M -$5.5M
EBIT -- -- -- -$1.9M -$5.7M
 
Revenue (Reported) -- -- -- $640.1K $1.3M
Operating Income (Reported) -- -- -- -$1.9M -$5.7M
Operating Income (Adjusted) -- -- -- -$1.9M -$5.7M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents -- -- -- $1.8M $703.4K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- $102.2K $163.3K
Inventory -- -- -- $364.2K $359.2K
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- $136.1K $48.1K
Total Current Assets -- -- -- $2.4M $1.3M
 
Property Plant And Equipment -- -- -- $566.7K $474.3K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- $684.9K $684.9K
Other Intangibles -- -- -- $622.6K $987.3K
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- $4.2M $3.4M
 
Accounts Payable -- -- -- $51K $169.1K
Accrued Expenses -- -- -- $159.7K $141.7K
Current Portion Of Long-Term Debt -- -- -- -- $343.8K
Current Portion Of Capital Lease Obligations -- -- -- $62.5K $68.5K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- $1.4M $1.4M
 
Long-Term Debt -- -- -- $146K $146K
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $1.7M $1.7M
 
Common Stock -- -- -- $1.4K $1.5K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- $2.6M $1.8M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- $2.6M $1.8M
 
Total Liabilities and Equity -- -- -- $4.2M $3.4M
Cash and Short Terms -- -- -- $1.8M $703.4K
Total Debt -- -- -- $146K $489.8K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- -- $2.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- $221.5K
Inventory -- -- -- -- $375.3K
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- $418.2K
Total Current Assets -- -- -- -- $3.3M
 
Property Plant And Equipment -- -- -- -- $444.1K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- $684.9K
Other Intangibles -- -- -- -- $988.2K
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- -- $5.5M
 
Accounts Payable -- -- -- -- $233.7K
Accrued Expenses -- -- -- -- $244.8K
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- $70K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- -- $1M
 
Long-Term Debt -- -- -- -- $146K
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- -- $1.2M
 
Common Stock -- -- -- -- $1.4K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -- $4.2M
 
Total Liabilities and Equity -- -- -- -- $5.5M
Cash and Short Terms -- -- -- -- $2.3M
Total Debt -- -- -- -- $146K
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- -- -- -$507.6K -$6.3M
Depreciation & Amoritzation -- -- -- $105.4K $239K
Stock-Based Compensation -- -- -- -- $3.6M
Change in Accounts Receivable -- -- -- $1.6M -$61.2K
Change in Inventories -- -- -- -$297.1K $5.1K
Cash From Operations -- -- -- $1.1M -$2M
 
Capital Expenditures -- -- -- $26.3K $30.2K
Cash Acquisitions -- -- -- $195.9K --
Cash From Investing -- -- -- $169.6K -$30.2K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- $50K $475K
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$721.9K -$495.1K
Cash From Financing -- -- -- $503.6K $985.2K
 
Beginning Cash (CF) -- -- -- -- $1.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $1.8M -$1M
Ending Cash (CF) -- -- -- $1.8M $703.4K
 
Levered Free Cash Flow -- -- -- $1.1M -$2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$679.8K -$3.7M
Depreciation & Amoritzation -- -- -- $59.8K $99.6K
Stock-Based Compensation -- -- -- -- $2.4M
Change in Accounts Receivable -- -- -- -$92.1K -$180.1K
Change in Inventories -- -- -- -$51.2K -$10.7K
Cash From Operations -- -- -- -$581.7K -$1.9M
 
Capital Expenditures -- -- -- $28.7K $2.9K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$28.8K -$2.9K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $596.3K $126.5K
Long-Term Debt Repaid -- -- -- -- -$236.5K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$11.1K -$2.2K
Cash From Financing -- -- -- $585.2K $4.1M
 
Beginning Cash (CF) -- -- -- $665.3K $176K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$25.2K $2.2M
Ending Cash (CF) -- -- -- $640.1K $2.3M
 
Levered Free Cash Flow -- -- -- -$610.4K -$1.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- -$10.5M
Depreciation & Amoritzation -- -- -- -- $283.3K
Stock-Based Compensation -- -- -- $113.2K $6.5M
Change in Accounts Receivable -- -- -- -- $198.9K
Change in Inventories -- -- -- -- -$10.7K
Cash From Operations -- -- -- -- -$3.3M
 
Capital Expenditures -- -- -- $28.7K $227.8K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- -$2.7K
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$195.1K
Cash From Financing -- -- -- -- $5.2M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- $1.7M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- -$3.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$1.9M -$6M
Depreciation & Amoritzation -- -- -- $178.3K $222.6K
Stock-Based Compensation -- -- -- $113.2K $2.9M
Change in Accounts Receivable -- -- -- -$318.2K -$58.2K
Change in Inventories -- -- -- -$320 -$16.1K
Cash From Operations -- -- -- -$1.8M -$3.1M
 
Capital Expenditures -- -- -- $28.7K $226.4K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$28.8K -$226.4K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $989.3K $511.5K
Long-Term Debt Repaid -- -- -- -- -$236.5K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$320.7K -$20.7K
Cash From Financing -- -- -- $668.6K $4.9M
 
Beginning Cash (CF) -- -- -- $3.2M $1.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$1.1M $1.6M
Ending Cash (CF) -- -- -- $2.1M $2.9M
 
Levered Free Cash Flow -- -- -- -$1.8M -$3.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SCHD a Good ETF to Buy?
Is SCHD a Good ETF to Buy?

With around $65.7 billion in net assets, Schwab’s US Dividend…

Is NAIL a Good ETF to Buy?
Is NAIL a Good ETF to Buy?

If you’re thinking about buying the NAIL ETF, this article…

3 High Dividend Dow Jones Stocks
3 High Dividend Dow Jones Stocks

Thanks to surging stock prices over the past two years,…

Stock Ideas

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 125x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
50
NARI alert for Jan 7

Inari Medical [NARI] is up 22.25% over the past day.

Buy
70
PDEX alert for Jan 7

Pro-Dex [PDEX] is down 10.89% over the past day.

Buy
52
ALCO alert for Jan 7

Alico [ALCO] is down 3.89% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock